- Global Pharma News & Resources

Press Releases - 2021-03-31

Date Title Company
31-Mar-2021 Americans Left in Limbo Over Lower Drug Costs Newswire
31-Mar-2021 Seegnal’s Drug Interaction Prevention Platform 20-fold More Accurate than Standard Tech Seegnal
31-Mar-2021 Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site Panthera Biopartners
31-Mar-2021 Abivax reports 2020 financial results and operations update (news with additional features) ABIVAX
31-Mar-2021 Annual General Meeting – shareholders approve all motions of the Board of Directors COLTENE Holding AG
31-Mar-2021 Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents BioNTech
31-Mar-2021 Specialist pharma Amzell B.V. signs agreement with Amring Pharmaceuticals develop and commercialize clinical-stage candidate Amzell B.V
31-Mar-2021 Strong support for health and care reforms but clarity needed on ministerial involvement in NHS NHS Confederation
31-Mar-2021 Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine Sanofi
31-Mar-2021 Cardinal Health Partners with FourKites to Build Cognitive Supply Chain FourKites
31-Mar-2021 VMS BioMarketing Names Tom Fagan as Chief Operating Officer Newswire
31-Mar-2021 Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept (“PoC”) Agreement for Two Ophthalmic Drug Candidates Nanoform Finland Plc
31-Mar-2021 Five New 'Key Opinion Leaders' Appointed to Blinkcns Scientific Advisory Board Newswire
31-Mar-2021 Global Cell and Gene Therapy Market Prophecy Market Insights
31-Mar-2021 Global Oncology Biosimilar Treatment Market is estimated to be US$ 44439.4 million by 2030 with a CAGR of 57.6% during the forecast period Prophecy Market Insights
31-Mar-2021 Global Cell and Gene Therapy Market worth US$ 1.8 billion 2019 with a CAGR of 35.60% Prophecy Market Insights
31-Mar-2021 Celltrion Healthcare receives positive CHMP opinion for subcutaneous formulation of infliximab, Remsima® SC, for direct use of subcutaneous therapy without IV loading in adults with rheumatoid arthritis Celltrion Healthcare
31-Mar-2021 National Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN) National Horizons Centre
31-Mar-2021 Bachem announces the launch of their new website Bachem
31-Mar-2021 New Equilibrium Bio raises $10M from RA Capital for AI-powered quantum chemistry Newswire